HCPCS Code C9142

Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Code effective Jan 01, 2023

HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System

C9142 is a valid 2026 HCPCS code meaning Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg or (Inj, alymsys, 10 mg) for short. HCPCS C9142 has been effective since 01/01/2023 and applies to Medical care.

HCPCS Code Details - C9142

HCPCS Level II Code
Section C - Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9142
Description

Long description:
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

Short description:
Inj, alymsys, 10 mg

HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Statute number 1833(t)
Coverage code D - Special coverage instructions apply
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2023
Date added Added Oct 01, 2022
Termination date Dec 31, 2022

See also

  • HCPCS C9141 · Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.

  • HCPCS Q5126 · Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

  • HCPCS C9143 · Cocaine hydrochloride nasal solution (numbrino), 1 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.